Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3049233	u-orgah	— (—)	102	118	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of psychological development

9.90

28.62

1.0

1.3

—

Epilepsy

6.16

17.09

1.3

1.1

—

Any mental disorder

8.62

16.98

1.1

1.2

—

Speech and linguistic disorders, excluding more controls

17.57

16.70

1.0

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

5.30

15.65

1.2

1.1

—

Delayed milestone in childhood

6.06

15.27

1.2

—

Speech and linguistic disorders

5.49

14.97

1.1

1.2

—

Care involving use of rehabilitation procedures

5.13

13.79

1.2

—

Mental retardation, excluding more controls

19.66

13.57

1.3

1.4

—

Psychiatric diseases

7.12

13.06

1.0

1.2

—

Motor disorders, excluding more controls

17.71

13.02

1.1

1.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.88

12.90

1.1

1.2

—

Mixed specific developmental disorders

10.81

12.66

1.1

1.4

—

Procreative management

4.87

12.16

1.0

1.2

—

Intestinal infectious diseases

4.10

11.68

1.1

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.81

11.39

1.2

—

Persons encountering health services for specific procedures and health care

3.86

11.15

1.2

—

Hyperkinetic disorders, excluding more controls

14.39

10.99

1.1

1.3

—

Specific developmental disorder of motor function

11.18

10.94

1.1

1.4

—

Motor disorders

5.52

10.38

1.1

1.2

—

Lack of expected normal physiological development

8.91

10.04

1.1

1.2

—

Mental retardation, wide definition

5.14

9.75

1.3

1.2

—

Mental retardation

5.15

9.75

1.3

1.2

—

Specific development disorders of speech and language

8.43

9.50

1.0

1.3

—

Nausea and vomiting

4.78

9.02

1.2

1.1

—

Disorders of refraction and accommodation

4.36

8.54

1.0

1.1

—

Other problems related to primary support group, including family circumstances

4.36

8.47

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.69

7.97

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.96

7.90

1.2

—

Viral and other specified intestinal infections

4.20

7.70

1.1

1.2

—

Hyperkinetic disorders

4.18

7.67

1.2

—

Specific development disorders of scholastic skills

13.22

7.32

1.2

1.1

—

Diseases of the myoneural junction and muscle

15.75

7.22

1.2

1.1

—

Focal epilepsy

6.01

7.05

1.4

1.1

—

Endocrine, nutritional and metabolic diseases

3.38

7.01

1.2

1.1

—

Strabismus

3.84

6.94

1.4

1.1

—

Convulsions, not elsewhere classified

6.87

6.91

1.4

1.2

—

Medical observation and evaluation for suspected diseases and conditions

7.90

6.83

1.1

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

9.31

6.78

1.2

1.0

—

Other strabismus

4.08

6.76

1.4

1.2

—

Focal epilepsy, strict definition

6.08

6.75

1.4

1.1

—

Viral and other specified intestinal infections

4.26

6.70

1.1

1.2

—

Other disorders starting during childhood or adolecense, excluding more controls

8.93

6.58

1.2

1.3

—

Metabolic disorders

3.60

6.30

1.3

1.2

—

Headache

5.66

6.18

1.1

1.2

—

Codes for special purposes

3.95

6.14

1.3

1.1

—

Astigmatism

6.68

6.02

1.2

—

Neurological diseases

3.02

5.96

1.2

1.1

—

Anxiety disorders, excluding more controls

7.69

5.61

1.1

1.4

—

Other symptoms and signs involving the nervous and musculoskeletal systems

4.72

5.59

1.2

—

Wide developmental disorders, excluding more controls

9.90

5.47

1.1

1.4

—

Visual disturbances and blindness

3.72

5.35

1.3

1.2

—

Hypoglycaemia, other or unspecified

7.88

5.34

1.3

1.0

—

Cardiomyopathy

11.26

5.28

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

6.64

5.24

1.2

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.58

5.19

1.1

—

Provisional assignment of new diseases of uncertain etiology

3.63

5.18

1.3

1.2

—

Disorders of other endocrine glands

3.04

5.17

1.2

1.1

—

Diseases of the eye and adnexa

3.16

5.16

1.2

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

10.72

5.12

1.2

1.0

—

Disturbance of activity and attention

4.49

5.06

1.2

—

Malaise and fatigue

5.81

4.96

1.2

1.3

—

Other reaction to severe stress, and adjustment disorders

7.70

4.84

1.1

—

Benzodiazepine use

3.55

4.80

1.4

1.2

—

Persons encountering health services in circumstances related to reproduction

2.84

4.80

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.66

4.78

1.1

1.2

—

Pain, not elsewhere classified

9.00

4.78

1.3

1.1

—

Episodal and paroxysmal disorders

2.54

4.69

1.3

1.1

—

Any gastric operation

2.94

4.63

1.3

1.1

—

GASTRO-related operations

2.94

4.63

1.3

1.1

—

Disorders of speech understanding and production

4.60

4.59

1.0

1.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.10

4.59

1.1

—

Congenital malformations of the nervous system

8.25

4.57

1.2

1.5

—

Implicit Sepsis

3.29

4.44

1.2

—

General symptoms and signs

3.28

4.34

1.1

1.2

—

Nystagmus and other irregular eye movements

11.79

4.28

1.4

1.0

—

Covid-19 confirmed case

4.80

4.17

1.2

—

Complications of medical and surgical care

4.43

4.14

1.1

—

Other functional intestinal disorders

2.80

4.05

1.3

1.1

—

Complications of surgical and medical care, not elsewhere classified

3.42

4.05

1.1

1.2

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

4.62

4.05

1.4

1.2

—

Fever of other and unknown origin

4.29

4.01

1.1

1.2

—

Implicit Sepsis

2.92

3.91

1.2

—

Other and unspecified mental retardation

4.10

3.89

1.5

1.3

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.21

3.79

1.3

1.2

—

Any death

6.44

3.74

1.2

1.0

—

Symptoms and signs involving the digestive system and abdomen

2.46

3.72

1.3

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

8.55

3.71

1.3

1.5

—

Mood disorders, excluding more controls

6.71

3.68

1.1

1.0

—

Cerebral palsy and other paralytic syndromes

5.63

3.65

1.6

1.0

—

Other disorders of eye and adnexa

5.63

3.65

1.3

—

Emotional disorders and disorders of social functioning with onset specific to childhood

4.93

3.63

1.2

1.4

—

Acute upper respiratory infections of multiple and unspecified sites

3.09

3.58

1.1

1.0

—

Complications of procedures, not elsewhere classified

4.33

3.47

1.1

1.0

—

Examination and observation for other reasons

5.26

3.45

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.46

3.43

1.1

1.2

—

Gastro-oesophageal reflux disease

3.62

3.42

1.3

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.70

3.41

1.2

—

Influenza and pneumonia

2.26

3.38

1.2

1.1

—

All influenza (not pneumonia)

5.72

3.34

1.1

—

Pervasive developmental disorders excl. Autism + Asperger

5.72

3.32

1.0

1.5

—

Other congenital malformations of brain

8.80

3.28

1.3

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.14

3.24

1.4

1.0

—

3.14

3.24

1.4

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.80

3.20

1.0

1.1

—

Acute pharyngitis

4.14

3.16

1.1

1.0

—

Neurotic, stress-related and somatoform disorders

2.97

3.11

1.1

—

Anxiety disorders

2.96

3.09

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.60

3.05

1.0

—

Implicit viral Sepsis

5.00

3.05

1.3

—

Viral Sepsis

5.00

3.05

1.3

—

Any reimbursement code in KELA

2.75

3.02

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

2.58

3.01

1.3

1.1

—

Hypermetropia

4.29

2.99

1.2

—

Systemic connective tissue disorders

10.00

2.98

1.0

—

All influenza

3.85

2.97

1.1

1.2

—

Intestinal infectious diseases

2.26

2.94

1.0

1.2

—

Visual disturbances

3.24

2.92

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

2.54

2.90

1.3

1.1

—

Hypothyroidism, levothyroxine purchases

6.60

2.89

1.0

—

Hypothyroidism and >3 levothyroxin purchases

6.60

2.89

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

7.94

2.88

1.2

1.0

—

Abnormalities of breathing

2.28

2.88

1.1

1.2

—

Other and unspecified tonsillitis

3.26

2.87

1.1

1.0

—

Abnormalities of gait and mobility

5.39

2.87

1.1

1.3

—

Other arrhythmias

3.77

2.80

1.0

1.1

—

Haemolytic anaemias

8.36

2.75

1.0

1.8

—

Open wound of ankle and foot

8.34

2.75

1.0

1.2

—

Cardiomyopathies, Primary/intrinsic

8.34

2.75

1.2

1.0

—

Cardiomyopathy (excluding other)

8.34

2.75

1.2

1.0

—

Disturbances of skin sensation

8.34

2.75

1.0

1.2

—

Cerebral palsy

5.04

2.73

1.6

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.24

2.72

1.1

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.39

2.71

1.2

—

Disorders of conjunctiva

2.23

2.70

1.5

1.1

—

Visual impairment including blindness (binocular or monocular)

6.01

2.70

1.2

1.1

—

Diseases of oesophagus, stomach and duodenum

2.48

2.67

1.2

—

Excessive, frequent and irregular menstruation

5.48

2.58

1.0

—

Persons encountering health services for examination and investigation

4.10

2.55

1.1

1.0

—

Dilated cardiomyopathy

7.15

2.55

1.2

1.0

—

Ulcerative colitis

7.14

2.55

1.2

1.0

—

Symptoms and signs concerning food and fluid intake

5.45

2.54

1.3

1.0

—

Gastrointestinal diseases

2.28

2.53

1.3

1.1

—

Asthma (mode)

3.57

2.51

1.1

1.0

—

All pneumoniae

2.05

2.46

1.3

1.1

—

Asthma

3.49

2.45

1.1

1.0

—

Implicit bacterial Sepsis

5.32

2.45

1.2

1.1

—

Asthma, excluding more controls

3.48

2.44

1.1

1.0

—

Wide developmental disorders

3.13

2.43

1.1

1.3

—

Heterophoria

5.01

2.40

1.0

1.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.02

2.39

1.1

1.0

—

Depression or dysthymia

4.83

2.39

1.1

1.0

—

Intermittent heterotropia

3.34

2.39

1.3

—

Nonischemic cardiomyopathy

6.25

2.37

1.2

1.1

—

Acute tubulo-interstitial nephritis

2.55

2.37

1.4

1.1

—

Otalgia

4.12

2.36

1.0

1.1

—

Use of hypnotics and sedatives

2.32

2.34

1.4

1.2

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

6.60

2.34

1.2

1.0

—

Conjunctivitis (acute, non atopic)

2.49

2.33

1.3

1.1

—

Other pulmonary diagnosis

3.34

2.33

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

3.34

2.33

1.1

1.0

—

COPD differential diagnosis

3.34

2.33

1.1

1.0

—

ILD differential diagnosis

3.34

2.33

1.1

1.0

—

Other disorders starting during childhood or adolescence

2.40

2.32

1.3

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.31

2.30

1.4

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.31

2.29

1.4

1.1

—

Nerve, nerve root and plexus disorders

3.44

2.29

1.1

1.0

—

Mild mental retardation

4.64

2.27

1.0

1.1

—

Other diseases of the respiratory system

4.62

2.27

1.2

1.1

—

Other respiratory disorders and diseases

4.62

2.27

1.2

1.1

—

Cardiac arrhythmias

2.69

2.25

1.0

1.1

—

Birth asphyxia

5.66

2.22

1.6

1.4

—

Diseases of the respiratory system

3.47

2.22

1.1

1.0

—

Immunodeficiencies

5.57

2.21

1.0

1.6

—

5-aminosalicylic acid

5.56

2.21

1.2

1.1

—

Conjunctivitis

2.12

2.21

1.5

1.1

—

Cough

2.41

2.18

1.2

—

Inflammatory bowel disease

4.29

2.15

1.2

1.1

—

Other anxiety disorders

3.30

2.12

1.1

—

Implicit bacterial Sepsis

4.32

2.11

1.2

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.98

2.11

1.0

1.2

—

Certain conditions originating in the perinatal period

2.30

2.11

1.4

1.1

—

Acute upper respiratory infections

2.40

2.10

1.1

1.0

—

Autoimmune diseases related-to ILD

2.61

2.09

1.1

—

Implicit viral Sepsis

3.20

2.09

1.3

1.2

—

Abdominal and pelvic pain

2.03

2.08

1.1

—

Hypothyroidism (congenital or acquired)

3.95

2.08

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

2.00

2.06

1.5

1.1

—

Amblyopia ex anopsia

3.51

2.05

1.4

1.3

—

Transplanted organ and tissue status

3.50

2.05

1.0

1.3

—

Dialysis, with operation codes

4.00

2.04

1.0

1.3

—

Certain infectious and parasitic diseases

2.04

2.02

1.4

1.1

—

Concussion

2.45

2.02

1.1

—

Persons encountering health services in other circumstances, wide

1.91

1.97

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.93

1.96

1.1

—

Irregular menses

3.95

1.95

1.2

1.0

—

Myopia

4.55

1.94

1.2

1.1

—

Symptoms and signs involving speech and voice

4.55

1.94

1.0

1.1

—

Keratitis

4.55

1.94

1.0

1.1

—

Other eating disorders

4.55

1.94

1.4

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

4.56

1.94

1.2

1.5

—

Otitis media, unspecified

2.47

1.93

1.3

1.1

—

Certain disorders involving the immune mechanism

3.75

1.93

1.0

1.3

—

Nutritional anaemias

2.97

1.92

1.0

1.2

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.56

1.92

1.5

1.1

—

Exclusions for E4_PCOS_BROAD

2.44

1.92

1.0

1.2

—

Emotional disorders starting during childhood or adolescence

2.94

1.91

1.3

—

Bacterial pneumonia, not elsewhere classified

3.77

1.91

1.2

1.1

—

Asthma (only as main-diagnosis)

3.09

1.86

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.88

1.86

1.3

1.1

—

Sleep apnoea, including avohilmo

2.79

1.85

1.0

1.1

—

Asthma (only as main-diagnosis), excluding more controls

3.05

1.84

1.1

1.0

—

Nonsuppurative otitis media

2.31

1.82

1.2

1.1

—

Bacterial Sepsis

3.15

1.82

1.1

1.3

—

Other headache syndromes

4.16

1.82

1.0

1.1

—

Eating disorders

4.16

1.82

1.4

1.1

—

Eating disorder

4.16

1.82

1.4

1.1

—

Infections, IBD-co-morbidities

4.46

1.81

1.0

—

Congenital malformations of the circulatory system

2.12

1.80

1.2

—

Disorders of sclera, cornea, iris and ciliary body

3.04

1.79

1.0

—

Other and unspecified iron deficiency

3.04

1.79

1.0

1.2

—

Abnormalities of heart beat

4.09

1.79

1.0

1.4

—

Abnormal findings on examination of blood, without diagnosis

3.06

1.79

1.3

1.0

—

Allergic asthma (mode)

4.08

1.79

1.0

—

Allergic asthma (mode), excluding more controls

4.08

1.79

1.0

—

Abnormal serum enzyme levels

4.06

1.78

1.4

1.0

—

STROKE

4.25

1.74

1.0

—

Cerebrovascular diseases

3.51

1.74

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.83

1.72

1.3

1.1

—

Inflammatory diseases of female pelvic organs

4.08

1.71

1.2

1.0

—

Artificial joint operation, meniscal resection

4.06

1.67

1.0

—

Dizziness and giddiness

2.64

1.66

1.0

1.1

—

Aplastic and other anaemias

2.84

1.66

1.1

1.3

—

Anaemias

2.51

1.65

1.1

1.3

—

Symptoms and signs involving the skin and subcutaneous tissue

2.17

1.65

1.0

1.2

—

Other medical care

3.17

1.64

1.2

1.1

—

Allergic conjunctivitis

2.44

1.64

1.5

1.2

—

Hypothyroidism, other/unspecified

2.33

1.62

1.1

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.33

1.61

1.1

1.0

—

Bacterial pneumoniae

3.11

1.61

1.2

1.1

—

Acute sinusitis

3.09

1.61

1.0

1.1

—

Neurological diseases, wide definition

2.13

1.59

1.1

—

Hypopituitarism

2.69

1.58

1.0

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.72

1.58

1.1

1.0

—

Other and unspecified anaemias

3.01

1.57

1.2

1.3

—

Other anaemias

3.00

1.57

1.2

1.3

—

Other congenital malformations

2.20

1.56

1.1

1.2

—

Pneumonia, organism unspecified

1.85

1.56

1.3

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

2.00

1.55

1.1

1.2

—

Iron deficiency anaemia

2.65

1.55

1.0

1.2

—

Mouth breathing

2.03

1.53

1.1

1.2

—

Other postsurgical states

3.34

1.52

1.2

1.4

—

Other diseases of pleura

2.92

1.51

1.2

1.3

—

Open bite

2.86

1.50

1.5

1.2

—

Heart failure, not strict

2.34

1.50

1.0

1.2

—

Other disorders of skin and subcutaneous tissue

2.59

1.49

1.1

1.3

—

Explicit Sepsis

2.40

1.46

1.1

—

Other congenital malformations

2.22

1.46

1.1

1.2

—

Polycystic ovarian syndrome, consortium definition

2.96

1.45

1.2

1.0

—

Bronchitis

2.05

1.44

1.1

1.0

—

Oral corticosteroids

2.32

1.40

1.2

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.65

1.38

1.2

1.0

—

2.03

1.36

1.1

1.0

—

Nephropathy related operations

2.94

1.36

1.0

1.3

—

Other diseases of blood and blood-forming organs, wide

2.94

1.36

1.0

1.1

—

Childhood asthma (age<16)

3.03

1.35

1.2

1.0

—

Childhood asthma (age<16), excluding more controls

3.03

1.35

1.2

1.0

—

Bacterial pneumonia (organism specified)

2.59

1.34

1.2

—

Other endocrine disorders

1.99

1.34

1.5

1.2

—

All kidney diseases

1.79

1.34

1.3

1.1

—

Disorders of the thyroid gland

2.11

1.32

1.1

1.0

—

Intracranial trauma

2.01

1.31

1.1

—

Cerebrovascular diseases (FINNGEN)

2.95

1.30

1.0

1.3

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

2.50

1.30

1.2

1.3

—

Noninflammatory disorders of female genital tract

3.14

1.30

1.0

—

Other disorders originating in the perinatal period

2.38

1.30

2.0

1.1

—

Impetigo

2.78

1.28

1.0

1.3

—

All anxiety disorders

2.34

1.28

1.1

—

Other diseases of intestines

1.65

1.28

1.3

1.1

—

Dental caries

2.06

1.27

1.0

1.2

—

Hyperkinetic disorders (excl. ADHD)

2.76

1.27

1.0

1.4

—

Renal tubulo-interstitial diseases

1.86

1.27

1.4

1.1

—

Genitourinary diseases

1.67

1.26

1.2

—

Type 2 diabetes

2.92

1.25

1.2

1.0

—

Other neurological diseases

2.24

1.24

1.4

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.79

1.22

1.1

1.2

—

Other nutritional deficiencies

2.15

1.20

1.0

1.3

—

Short stature, not elsewhere classified

1.97

1.20

1.2

—

Septicaemia

2.14

1.19

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

2.31

1.18

1.2

—

COPD/asthma/ILD related infections

2.04

1.16

1.1

1.0

—

COPD/asthma related infections

2.04

1.16

1.1

1.0

—

L04AA Selective immunosuppressants

2.50

1.15

1.0

1.3

—

Anxiety (asthma-related co-morbidities)

2.06

1.14

1.1

—

Sleep apnoea

2.38

1.13

1.0

1.1

—

Childhood allergy (age < 16)

1.75

1.09

1.3

1.1

—

Other septicaemia

2.17

1.07

1.1

—

Noninfective enteritis and colitis

1.86

1.06

1.1

1.2

—

Diseases of the ear and mastoid process

1.67

1.05

1.1

—

ILD medications: immunosuppressive drugs

1.80

1.04

1.2

—

Cardiovascular diseases

1.57

1.04

1.0

1.2

—

Other heart diseases, wide

1.62

1.03

1.1

1.2

—

Suppurative and unspecified otitis media

1.84

1.01

1.1

—

Depression

1.91

1.01

1.1

1.0

—

Dentofacial anomalies [including malocclusion]

1.70

1.01

1.0

1.2

—

Persons with potential health hazards related to communicable diseases

1.72

0.99

1.1

1.2

—

Congenital malformations of heart and great arteries

1.76

0.99

1.2

—

Renal failure

2.21

0.99

1.0

1.3

—

Acute bronchitis

1.84

0.98

1.2

—

Hypoplasia of dental enamel

0.00

0.98

0.0

1.3

—

Obesity due to excess calories

2.17

0.98

1.0

1.1

—

Mood [affective] disorders

1.82

0.96

1.1

1.0

—

Mood disorders

1.82

0.96

1.1

1.0

—

Caries of enamel

1.59

0.95

1.1

1.2

—

Diseases of middle ear and mastoid

1.75

0.95

1.1

—

Dyspnoea

1.81

0.94

1.2

—

Other and unspecified effects of external causes

1.89

0.94

1.1

1.3

—

Tonsillectomy and adenotomy

1.58

0.92

1.2

—

L04AD Calcineurin inhibitors

2.14

0.91

1.0

1.2

—

Disorders of gallbladder, biliary tract and pancreas

1.94

0.90

1.0

1.3

—

Viral warts

2.07

0.89

1.3

1.1

—

Disorders of skin appendages

2.07

0.89

1.0

—

Obesity

2.07

0.89

1.0

1.1

—

Obesity and other hyperalimentation

2.06

0.89

1.0

1.1

—

Acute suppurative otitis media

1.79

0.88

1.1

—

Caries of dentine

1.95

0.84

1.0

1.3

—

Constipation

1.56

0.84

1.4

1.1

—

All chronic kidney diseases

1.78

0.84

1.5

1.2

—

Congenital malformations of genital organs

1.86

0.81

1.0

1.3

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.78

0.0

1.2

—

Contact with and exposure to communicable diseases

1.66

0.77

1.1

1.2

—

Accidents

0.53

0.76

1.0

1.2

—

Other external causes of accidental injury

0.53

0.76

1.0

1.2

—

Respiratory distress of newborn

1.68

0.75

1.1

1.2

—

Other disorders of penis

2.08

0.74

1.0

1.2

—

Acute laryngitis and tracheitis

2.05

0.73

1.2

1.0

—

Inflammatory bowel disease treatment related agents

1.52

0.73

1.1

1.2

—

Migraine without aura

2.00

0.72

1.2

1.0

—

Paroxysmal tachycardia

1.99

0.72

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.49

0.72

1.2

—

Intracranial injury

1.63

0.72

1.1

1.2

—

Other viral diseases, not elsewhere classified

1.60

0.72

1.1

1.2

—

Symptoms and signs involving the urinary system

1.59

0.71

1.0

1.2

—

Gingivitis and periodontal diseases

0.53

0.70

1.2

—

Injuries to the ankle and foot

1.57

0.69

1.1

1.2

—

Atopic dermatitis, strict definition

1.55

0.66

1.5

1.1

—

Used for control exclusion in common control thyroid runs

1.40

0.64

1.1

1.2

—

Caries of dentine, including avohilmo

0.64

1.0

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.73

0.64

2.0

1.1

—

Other viral diseases

1.53

0.63

1.1

1.2

—

Other noninfective gastroenteritis and colitis

1.63

0.62

1.1

1.2

—

Effects of foreign body entering through natural orifice

1.67

0.61

1.0

1.2

—

Other viral diseases, not elsewhere classified

1.54

0.60

1.1

1.2

—

Other acute lower respiratory infections

1.54

0.60

1.1

1.2

—

Anomalies of dental arch relationship, including avohilmo

1.58

0.60

1.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.60

0.0

1.2

—

Scabies

0.00

0.59

0.0

1.2

—

Certain infectious and parasitic diseases

1.54

0.59

1.1

—

Pediculosis, acariasis and other infestations

0.00

0.58

0.0

1.2

—

Crossbite

1.51

0.58

1.0

1.2

—

Chronic diseases of tonsils and adenoids

1.44

0.57

1.2

—

Atopic dermatitis, strict definition with reimbursement

1.52

0.57

1.5

1.1

—

Pain (limb, back, neck, head abdominally)

1.45

0.57

1.1

1.2

—

Crowding of teeth, including avohilmo

1.47

0.56

1.0

1.3

—

Atrial septal defect, secundum type

1.66

0.56

1.3

—

Congenital malformations of cardiac septa

1.54

0.55

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.45

0.53

1.7

1.1

—

Atrial septal defect

1.53

0.52

1.3

1.2

—

Persons encountering health services in other circumstances

1.49

0.51

1.2

—

Parasetamol

1.61

0.51

1.0

—

Other disorders of ear

1.45

0.50

1.0

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.47

0.49

1.3

1.1

—

1.45

0.49

1.1

1.2

—

Other fall from one level to another

1.56

0.48

1.1

1.2

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.49

0.48

1.3

1.2

—

ILD medications

1.36

0.48

1.1

1.2

—

Pain in throat and chest

1.45

0.46

1.0

1.1

—

Other disorders of urethra and urinary system

1.44

0.46

1.1

1.2

—

Neoplasms

0.69

0.45

1.1

1.2

—

Exposure to other specified factors

1.42

0.44

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.00

0.43

0.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

1.41

0.42

1.1

1.2

—

Hypothyroidism, strict autoimmune

1.57

0.42

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.43

0.42

1.9

1.1

—

Chromosomal abnormalities, not elsewhere classified

1.56

0.42

1.0

1.3

—

Migraine with aura

0.00

0.41

0.0

1.1

—

Other and unspecified dermatitis

1.47

0.40

1.0

1.1

—

Other diseases of upper respiratory tract

1.30

0.39

1.1

1.2

—

Fracture of lower leg, including ankle

1.41

0.39

1.0

1.2

—

Acute bronchiolitis

1.37

0.38

1.1

1.2

—

Other viral diseases

1.40

0.38

1.1

1.2

—

Other antidepressants

1.54

0.38

1.2

1.0

—

Diabetes medication

0.62

0.36

1.2

—

Asthma, hospital admission 2, infections

1.36

0.36

1.1

1.2

—

Asthma-related infections

1.36

0.36

1.1

1.2

—

Diseases of male genital organs

1.39

0.36

1.0

1.2

—

Antihypertensive medication - note that there are other indications

1.33

0.34

1.1

1.2

—

Chronic lower respiratory diseases

1.25

0.34

1.1

1.2

—

Asthma/COPD (KELA code 203)

1.30

0.33

1.1

1.2

—

Pain in joint

1.32

0.33

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.25

0.32

1.1

1.2

—

Mycoses

1.29

0.30

1.0

1.1

—

Second line medication for Crohn's disease

1.27

0.30

1.1

—

Atopic dermatitis

1.29

0.29

1.4

1.1

—

Congenital malformations and deformations of the musculoskeletal system

1.22

0.28

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

0.68

0.27

1.2

—

Cystitis

0.66

0.26

1.0

1.2

—

Infections of the skin and subcutaneous tissue

1.30

0.26

1.0

1.2

—

Dental operations

1.25

0.26

1.2

—

Valvular heart disease excluding rheumatic fever

1.34

0.23

1.0

1.2

—

External causes of morbidity and mortality

0.75

0.23

1.0

1.2

—

Insomnia

1.30

0.23

1.0

1.1

—

Type 1 diabetes

1.31

0.23

1.2

1.3

—

Sub-endpoint used in defining T1D endpoints

1.29

0.23

1.2

1.3

—

Excessive earwax

1.25

0.22

1.6

1.2

—

Dermatitis

1.25

0.22

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

1.21

0.22

1.1

—

Benign neoplasms

1.26

0.22

1.1

1.2

—

Diabetic retinopathy, excluding more controls

0.00

0.22

0.0

1.1

—

Exposure to unspecified factor

1.21

0.22

1.0

1.2

—

Diseases of the digestive system

1.21

0.22

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.21

0.22

1.1

1.2

—

Diabetic retinopathy

0.00

0.21

0.0

1.1

—

Migraine

1.19

0.21

1.2

1.0

—

Coarctation of the aorta

0.00

0.21

0.0

1.1

—

Unspecified mental disorder

0.00

0.21

0.0

1.1

—

Poisoning by medicine

0.00

0.21

0.0

1.1

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.2

—

Poisoning by drugs, medicaments and biological substances

0.00

0.21

0.0

1.1

—

Autoimmune diseases excluding thyroid diseases

1.20

0.21

1.1

1.2

—

Injury of eye and orbit

0.00

0.21

0.0

1.1

—

Other cataract

0.00

0.21

0.0

1.0

—

Varicose veins

0.00

0.21

0.0

1.0

—

Other juvenile arthritis

0.00

0.21

0.0

1.4

—

Juvenile arthritis (FINNGEN)

0.00

0.21

0.0

1.1

—

Otitis externa, unspecified

0.00

0.21

0.0

1.1

—

Other disorders of bone

0.00

0.21

0.0

1.0

—

Chronic sinusitis

0.00

0.21

0.0

1.0

—

Missing teeth due to accident, extraction or parodontitis

0.00

0.20

0.0

1.0

—

Other bacterial diseases

0.77

0.20

1.1

1.2

—

Personal history of other diseases and conditions

1.17

0.19

1.3

1.2

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.15

0.19

1.0

1.2

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.15

0.19

1.0

1.2

—

Diabetes, varying definitions

1.25

0.18

1.2

—

Bleeding

1.21

0.18

1.1

1.2

—

Diabetes mellitus

1.24

0.18

1.2

—

Congenital malformations and deformations of the musculoskeletal system

1.18

0.18

1.1

1.2

—

Dermatitis and eczema

1.18

0.18

1.3

1.1

—

Malignant neoplasm

0.76

0.17

1.2

—

Vasomotor and allergic rhinitis

1.14

0.17

1.0

1.2

—

First line medication for Crohn's disease

1.17

0.17

1.1

1.2

—

Pain in limb

1.20

0.17

1.1

1.2

—

Other specific joint derangements/joint disorders

1.17

0.17

1.1

—

Diseases of pulp and periapical tissues and dental caries

0.83

0.16

1.0

1.2

—

Septal defects

1.17

0.16

1.3

1.2

—

Injury, poisoning and certain other consequences of external causes

0.80

0.15

1.0

1.2

—

Other joint disorders

0.80

0.14

1.1

1.2

—

Other diseases of urinary system

0.80

0.14

1.1

—

Soft tissue disorders

0.87

0.13

1.2

—

Hard cardiovascular diseases

1.17

0.12

1.0

1.2

—

Other congenital malformations of the digestive system

1.10

0.09

1.0

1.3

—

Dental pulpitis, including avohilmo

1.05

0.09

1.0

1.1

—

Arthropathies

0.87

0.09

1.3

1.2

—

Hypertensive diseases (excluding secondary)

1.09

0.09

1.0

1.3

—

Other heart diseases

1.14

0.09

1.1

1.2

—

L04AX Other immunosuppressants

1.11

0.09

1.2

1.1

—

Sleep disorders

1.08

0.09

1.2

1.1

—

Urticaria and erythema

1.09

0.08

1.0

1.2

—

Finngen Rheumatological endpoints

1.03

0.08

1.5

1.0

—

Haemorrhagic and haematological disorders of fetus and newborn

1.02

0.08

1.3

1.2

—

0.78

0.08

1.0

1.2

—

Unspecified fall

1.06

0.08

1.0

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.84

0.08

1.2

—

Injuries to the elbow and forearm

1.04

0.08

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

0.81

0.08

1.2

—

Sleep disorders (combined)

1.14

0.07

1.1

1.2

—

Other diseases of hard tissues of teeth

0.84

0.07

1.1

1.2

—

Percutaneous Coronary Intervention

0.86

0.07

1.0

1.2

—

Coronary revascularization (ANGIO or CABG)

0.86

0.07

1.0

1.2

—

Dental caries, including avohilmo

0.89

0.07

1.0

1.2

—

Emergency coronary revascularization (for ACS)

0.83

0.07

1.0

1.2

—

Injuries to the knee and lower leg

0.89

0.06

1.1

1.2

—

Other soft tissue disorders, not elsewhere classified

1.09

0.06

1.1

1.2

—

Autoimmune diseases

1.07

0.04

1.1

1.2

—

Fall on same level

0.93

0.04

1.2

—

Asthma, hospital admissions , main diagnosis only

1.08

0.02

1.1

1.2

—

Asthma, including avohilmo

1.06

0.02

1.1

1.2

—

Diseases of the musculoskeletal system and connective tissue

0.94

0.01

1.2

—

Asthma (diagnoses ohter than nonallergic)

1.06

0.01

1.1

1.2

—

Injuries to the wrist and hand

1.03

0.00

1.2

1.1

—

Injuries to the head

0.97

0.00

1.2

1.1

—

Falls/tendency to fall

1.03

0.00

1.1

1.2

—

Hyperlipidaemia, other/unspecified

0.00

0.0

1.0

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.0

1.1

—

Senile cataract

0.00

0.0

1.0

—

Functional dyspepsia

0.00

0.0

1.0

—

Allergic rhinitis

0.94

0.00

1.0

1.2

—

Lactose intolerance

0.00

0.0

1.0

—

Any event in cancer register

0.86

0.00

1.2

—

Malignant neoplasm of breast, HER2-negative

0.00

0.0

1.0

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.2

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.0

1.2

—

Other osteochondrodysplasias

0.00

0.0

1.2

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.0

1.0

—

Major coronary heart disease event

0.97

0.00

1.0

1.2

—

Disorders of vitreous body and globe

0.00

0.0

1.0

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.2

—

Operations 1 for CAVS

0.00

-0.00

0.0

1.2

—

Underdevelopment of the second kidney

0.00

-0.00

0.0

1.2

—

Other adrenocortical overactivity

0.00

-0.00

0.0

1.0

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.0

—

Diabetic retinopathy, strict definition

0.00

-0.00

0.0

1.2

—

Haemorrhoids and perianal venous thrombosis

0.00

-0.00

0.0

1.0

—

Irritable bowel syndrome

0.00

-0.00

0.0

1.0

—

Other sleep disorders

0.00

-0.00

0.0

1.0

—

D07AA Corticosteroids, weak (group I)

1.02

-0.00

1.2

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm

0.00

-0.00

0.0

1.0

—

Volume depletion

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.94

-0.00

1.0

1.2

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.2

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

1.1

—

Other bacterial diseases

1.01

-0.00

1.1

1.2

—

Other enthesopathies

0.00

-0.00

0.0

1.0

—

Renal agenesis and other reduction defects of kidney

0.00

-0.00

0.0

1.2

—

Other osteochondrodysplasias

0.00

-0.00

0.0

1.2

—

Birth trauma

0.00

-0.00

0.0

1.1

—

Renal agenesis and other reduction defects of kidney

0.00

-0.00

0.0

1.2

—

Dorsopathies

1.02

-0.00

1.0

1.1

—

Haemangioma and lymphangioma, any site

0.00

-0.00

0.0

1.6

—

Pneumonia derived septicemia

0.00

-0.00

0.0

1.5

—

1.01

-0.00

1.3

1.2

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

1.0

—

Haemangioma, any site

0.00

-0.00

0.0

1.7

—

Foreign body on external eye

0.00

-0.00

0.0

1.2

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of breast

0.00

-0.00

0.0

1.0

—

Contusion of ankle

0.00

-0.00

0.0

1.0

—

Chronic periodontitis, complicated

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of lower leg

0.00

-0.00

0.0

1.0

—

Other superficial injuries of ankle and foot

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of head

0.00

-0.00

0.0

1.2

—

Disorders of vitreous body

0.00

-0.00

0.0

1.0

—

Open wound of head

0.92

-0.00

1.2

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

-0.00

0.0

1.2

—

Contact with other hot metals

0.00

-0.00

0.0

1.0

—

Other disorders of veins

0.00

-0.00

0.0

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

-0.00

0.0

1.0

—

Nasal polyp

0.00

-0.00

0.0

1.0

—

Other respiratory diseases principally affecting the interstitium

0.00

-0.00

0.0

1.2

—

Scabies

0.00

-0.00

0.0

1.2

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.2

—

Contact with other sharp object(s)

0.00

-0.00

0.0

1.0

—

Fall involving bed

0.00

-0.00

0.0

1.0

—

Other congenital malformations of intestine

0.00

-0.00

0.0

1.0

—

Pain associated with micturition

0.00

-0.00

0.0

1.0

—

Idiopathic thrombocytopenic purpura

0.00

-0.00

0.0

1.2

—

Hypertension

0.97

-0.00

1.0

1.3

—

Maxillary retrognathism

0.00

-0.00

0.0

1.8

—

Other congenital malformations of ear

0.00

-0.00

0.0

1.2

—

Other otitis externa (chronic)

0.00

-0.00

0.0

1.2

—

Café au lait spots

0.00

-0.00

0.0

1.8

—

Exclusion endpoint for supernumerary teeth

0.00

-0.00

0.0

1.1

—

Maternal care for known or suspected abnormality of pelvic organs

0.00

-0.00

0.0

1.2

—

Other dorsopathies, not elsewhere classified

0.87

-0.00

1.0

1.1

—

Glaucoma

0.00

-0.00

0.0

1.0

—

Chondropathies

0.00

-0.00

0.0

1.0

—

Osteomyelitis

0.00

-0.00

0.0

1.0

—

Urticaria

1.02

-0.00

1.0

1.2

—

Migraine with aura and triptan purchases

0.00

-0.00

0.0

1.1

—

Seronegative juvenile rheumatoid arthritis

0.00

-0.00

0.0

1.2

—

Pneumococcal septicemia

0.00

-0.00

0.0

1.1

—

Torsion of testis

0.00

-0.00

0.0

1.2

—

Diseases of oral cavity, salivary glands and jaws

0.89

-0.00

1.3

1.2

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.2

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.2

—

Infectious mononucleosis

0.00

-0.00

0.0

1.0

—

Neonatal jaundice from other and unspecified causes

0.91

-0.00

1.4

1.2

—

Impacted maxillary canine

0.00

-0.00

0.0

1.1

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.2

—

Varicella [chickenpox]

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of breast, including Hilmo

0.00

-0.00

0.0

1.0

—

Impacted maxillary molar

0.00

-0.00

0.0

1.2

—

Aortic hypoplasia

0.00

-0.00

0.0

1.1

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.1

—

Pollen allergy

0.91

-0.00

1.0

1.2

—

Polycystic kidney disease

0.00

-0.00

0.0

1.2

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

-0.00

0.0

1.1

—

Prolonged pregnancy

0.00

-0.00

0.0

1.2

—

Acute alcohol intoxication, ICD10

0.00

-0.00

0.0

1.0

—

Mandibular prognathia

0.00

-0.00

0.0

1.2

—

Maternal care for known or suspected malpresentation of fetus

0.00

-0.00

0.0

1.2

—

Ischemic heart diseases

0.96

-0.00

1.0

1.2

—

Kela-code for severe mental illness

0.00

-0.00

0.0

1.0

—

Acute alcohol intoxication

0.00

-0.00

0.0

1.0

—

Other disorders of optic disc

0.00

-0.00

0.0

1.2

—

Scoliosis

0.00

-0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

1.0

—

Other congenital malformations of intestine

0.00

-0.00

0.0

1.0

—

Ganglion

0.00

-0.00

0.0

1.0

—

Other/unspecified dorsalgia

0.00

-0.00

0.0

1.3

—

Psoriasis vulgaris

0.00

-0.00

0.0

1.0

—

Dorsalgia

0.92

-0.00

1.0

1.1

—

Cleft lip, lip and palate or palate

0.00

-0.00

0.0

1.0

—

Scarlet fever

0.00

-0.00

0.0

1.2

—

Abrasion of teeth

0.00

-0.00

0.0

1.1

—

Hypertensive diseases

0.97

-0.00

1.0

1.3

—

Herpesviral [herpes simplex] infections

0.00

-0.00

0.0

1.2

—

Pectus excavatum

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Organic acids panel - Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS